These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8987254)

  • 1. Epidemiology.
    Eur J Haematol Suppl; 1996; 60():126-7. PubMed ID: 8987254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs, agranulocytosis and aplastic anemia].
    Lunde PK; Baksaas I
    Tidsskr Nor Laegeforen; 1986 Nov; 106(31):2639-41. PubMed ID: 3810581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dipyrone, the controversy].
    Borbolla Escoboza JF; Collados Larumbe MT
    Rev Invest Clin; 1994; 46(1):73-4. PubMed ID: 8079069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced hematological disorders].
    Nishimura J; Motomura S; Akagi T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():99-105. PubMed ID: 18074523
    [No Abstract]   [Full Text] [Related]  

  • 5. Analgesic risks and pharmacoepidemiology.
    Faich GA
    JAMA; 1986 Oct; 256(13):1788. PubMed ID: 3747091
    [No Abstract]   [Full Text] [Related]  

  • 6. Hematological toxicity of ticlopidine.
    Lesesve JF; Callat MP; Lenormand B; Monconduit M; Noblet C; Moore N; Caron F; Humbert G; Stamatoullas A; Tilly H
    Am J Hematol; 1994 Oct; 47(2):149-50. PubMed ID: 8092140
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
    Levy M; Kelly JP; Kaufman DW; Shapiro S
    Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis and aplastic anemia among Ramathibodi Hospital patients.
    Jootar S; Chaisiripoomkere W; Rojanasthien S
    J Med Assoc Thai; 1992 Sep; 75(9):514-6. PubMed ID: 1304020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative incidence of agranulocytosis and aplastic anemia.
    Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
    Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
    Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
    Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agranulocytosis and aplastic anemia induced by drugs].
    Laporte JR
    Med Clin (Barc); 1987 Apr; 88(13):555-8. PubMed ID: 3295412
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
    Rawson NS; Harding SR; Malcolm E; Lueck L
    J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study.
    Kramer MS; Lane DA; Hutchinson TA
    J Chronic Dis; 1987; 40(12):1073-85. PubMed ID: 3680465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
    Eur J Clin Pharmacol; 1983; 24(6):833-6. PubMed ID: 6884419
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Agranulocytosis and aplastic anemia possibly due to ibuprofen.
    Gryfe CI
    Can Med Assoc J; 1976 May; 114(10):877. PubMed ID: 1268773
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced blood dyscrasias.
    Casey TP
    N Z Med J; 1968 Jun; 67(433):599-606. PubMed ID: 4877026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.